It is a precision diagnostic panel that can be used to test for major genetic mutations related to solid tumors using NGS.
Guidance for cancer treatment based on NGS-based precision diagnostics
ONCOaccuPanel™ was jointly developed by Seoul Asan Medical Center and Harvard Dana-Farber Research Center after technology transfer and commercialization. This method makes it possible to test more than 300 genetic mutations from tissue specimens of solid cancer (around 35 cancer types including lung, colon, stomach, breast cancer, etc.).